Drug Information

Drug General Information
Drug ID
D04MLU
Former ID
DNC010156
Drug Name
[1-(4-p-Tolyl-butyl)-piperidin-4-yl]-methanol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530299]
Formula
C17H27NO
Canonical SMILES
CC1=CC=C(C=C1)CCCCN2CCC(CC2)CO
InChI
1S/C17H27NO/c1-15-5-7-16(8-6-15)4-2-3-11-18-12-9-17(14-19)10-13-18/h5-8,17,19H,2-4,9-14H2,1H3
InChIKey
VTDHRHRPPVJGSU-UHFFFAOYSA-N
PubChem Compound ID
45485499
Target and Pathway
Target(s) Potassium voltage-gated channel subfamily H member 2 Target Info Inhibitor [530299]
PathWhiz Pathway Muscle/Heart Contraction
Reactome Voltage gated Potassium channels
WikiPathways SIDS Susceptibility Pathways
Hematopoietic Stem Cell Differentiation
Potassium Channels
References
Ref 530299Bioorg Med Chem Lett. 2009 Sep 1;19(17):5043-7. Epub 2009 Aug 5.Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.
Ref 530299Bioorg Med Chem Lett. 2009 Sep 1;19(17):5043-7. Epub 2009 Aug 5.Structural determinants for histamine H(1) affinity, hERG affinity and QTc prolongation in a series of terfenadine analogs.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.